Clinical Trial Update: Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Sanofi's H7N9 influenza vaccine with and without AS03 adjuvant in adults and elderly has completed, with results posted in October 2020…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avian Influenza

Drugs mentioned

• H7N9 influenza vaccine with AS03 adjuvant (influenza vaccine H7N9)
• H7N9 influenza vaccine without AS03 adjuvant (influenza vaccine H7N9)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Avian Influenza, Influenza Immunisation | Phase 2 | Status: COMPLETED | Results posted: 2020-10-12